BioCryst announces inducement grants to 11 new employees

• BioCryst Pharmaceuticals' (NASDAQ:BCRX) compensation committee of the company board granted 11 newly-hired employees inducement options to purchase 84K shares on Nov.30.
• The options have an exercise price of $12.06/share and vest in four equal annual installments commencing on 1-year anniversary of the grant date.
• Each stock option has a 10-year term and is subject to BioCryst's Inducement Equity Incentive Plan and a stock option agreement covering the grant.
• Shares trading 1.2% down premarket